NASDAQ:INSY

INSYS Therapeutics Earnings Date, Estimates & History

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Compare
Today's Range N/A
50-Day Range
$0.23
MA: $23,687,640.18
$65,799,000.00
52-Week Range N/A
VolumeN/A
Average Volume9.52 million shs
Market Capitalization$21.71 million
P/E RatioN/A
Dividend YieldN/A
Beta3.21

Earnings

INSYS Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

INSYS Therapeutics (NASDAQ:INSY) Earnings Estimates

Current Year EPS Consensus Estimate: $-1.55 EPS
Next Year EPS Consensus Estimate: $-0.88 EPS

INSYS Therapeutics (NASDAQ INSY) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
5/10/20193/31/2019($0.22)($0.55)$0.50$14.95 million$7.63 millionN/A
3/7/201912/31/2018($0.29)($0.37)($0.16)$17.93 million$16.36 millionTranscript
11/5/20189/30/2018($0.32)($0.40)($0.39)$24.05 million$18.30 millionN/A
8/8/2018Q2 2018($0.16)($0.33)($0.37)$25.91 million$23.47 millionN/A
5/8/2018Q1 2018($0.18)($0.19)($0.16)$25.82 million$23.90 millionN/A
3/8/2018Q4 2017($0.14)($0.61)$0.19$34.00 million$31.49 millionTranscript
11/2/2017Q3 2017($0.23)($0.25)$1.80$34.98 million$30.67 millionN/A
8/3/2017Q2 2017($0.09)$0.03$0.09$36.90 million$42.60 millionListen
5/9/2017Q1 2017($0.10)($0.09)($0.09)$37.78 million$35.92 millionListen
4/3/2017Q4 2016($0.0020)$0.03$0.03$52.08 million$54.86 millionN/A
11/3/2016Q316$0.02$0.07$55.97 million$55.20 millionN/A
8/3/2016Q216$0.07$0.06$0.06$66.90 million$67.10 millionListen
4/28/2016Q116$0.07$0.11$0.03$61.31 million$62.00 millionListen
2/23/2016Q415$0.29$0.36$0.22$91.04 million$91.10 millionListen
11/5/2015Q315$0.23$0.50$0.34$82.98 million$91.30 millionN/A
8/6/2015Q215$0.21$0.16$0.22$74.06 million$77.60 millionN/A
5/7/2015Q115$0.40$0.63$0.41$70.90 million$70.80 millionN/A
3/3/2015Q414$0.44$0.53$0.13$63.50 million$66.50 millionN/A
11/11/2014Q314$0.29$0.63$0.38$57.10 million$58.30 millionN/A
8/12/2014Q214$0.30$0.48$0.35$52.77 million$55.70 millionN/A
5/13/2014Q1 2014$0.14$0.18$0.25$46.00 million$41.64 millionN/A
3/4/2014Q4 2013$0.18$0.21$0.08$34.73 million$40.20 millionN/A
11/12/2013Q3 2013$0.11$0.17$0.17$27.00 million$29.20 millionListen
8/13/2013Q2 2013$0.05$0.09$0.09$15.07 million$18.80 millionN/A
6/3/2013Q113$0.01$2.00 million$11.10 millionN/A
8/26/2010Q2 2010($0.59)($0.59)N/A
6/11/2010Q1 2010($1.02)($1.02)N/A
3/18/2010Q4 2009($0.33)$0.42N/A
10/26/2009Q3 2009($1.26)($1.26)N/A
7/27/2009Q2 2009($1.42)($1.42)N/A
4/28/2009Q1 2009($1.61)($1.61)N/A
3/4/2009Q4 2008($1.59)($1.59)N/A
11/12/2008Q3 2008($1.71)($1.71)N/A
8/14/2008Q2 2008($1.48)($1.48)N/A
5/12/2008Q1 2008($1.08)($1.08)N/A
3/27/2008Q4 2007($0.75)($0.75)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 4/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.